Signal active
Organization
Contact Information
Overview
Clerkenwell Health is an innovative mental health company offering clinical research support services and psychedelic-assisted therapies.
By providing independent psychedelic-specialist CRO services, Clerkenwell will accelerate the adoption of these treatments across Europe.
The team are passionate about putting patients at the centre of clinical trial design and delivering gold standard therapy protocols.
About
Health Care, Pharmaceutical, Clinical Trials
2020
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Clerkenwell Health headquartered in Europe, operates in the Health Care, Pharmaceutical, Clinical Trials sector. The company focuses on Health Care and has secured $111.7M in funding across 48 round(s). With a team of 11-50 employees, Clerkenwell Health is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Clerkenwell Health, raised $2.3M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
4
5
0
$2.3M
Details
4
Clerkenwell Health has raised a total of $2.3M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | |||
2021 | Seed | |||
2022 | Seed | |||
2022 | Seed | 2.3M |
Investors
Clerkenwell Health is funded by 10 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Exceptional Ventures | - | FUNDING ROUND - Exceptional Ventures | 2.3M |
Matt Cooper | - | FUNDING ROUND - Matt Cooper | 2.3M |
Clerkenwell Health | - | FUNDING ROUND - Clerkenwell Health | 2.3M |
Christer Holloman | - | FUNDING ROUND - Christer Holloman | 2.3M |
Recent Activity
There is no recent news or activity for this profile.